Neoplasia/BPH

	Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes. Sci Rep Quinsten AS, Wetter A, Raczkowski M, Trembecki , Guz T, Oliveira S, Buchkremer R, Matusiewicz D, Nassenstein K, Forsting M, Demircio. PMID: 42115680 [PubMed - indexed for MEDLINE]
	Dissecting self-supervised learning strategies for transfer learning in MRI prostate cancer diagnosis. Sci Rep Facuse J, Campanini D, Parra D, Besa C, Salas R, Estévez PA, Mery D. PMID: 42115652 [PubMed - as supplied by publisher]
	Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial. World J Urol Zhang X, Wu Z, Hao L, Qiu X, Xu L, Zhang S, Guo H, Zhuang J. PMID: 42115448 [PubMed - indexed for MEDLINE]
	The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer. Oncogene Cheng B, Gong L, Xu H, Wang Z, Huang H, Guan X, Wu P. PMID: 42115408 [PubMed - as supplied by publisher]
	The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution. Virchows Arch Munari E, Antonini P, Cima L, Polati R, Caliò A, Gobbo STM, Colecchia M, Netto GJ, Antonelli A, Bertolo RG, Grisi C, Litjens G, Brunelli M. PMID: 42115324 [PubMed - as supplied by publisher]
	Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies. Urol Oncol Li J, Wang X, Tang X. PMID: 42115122 [PubMed - as supplied by publisher]
	Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Focus De Laere B, Crippa A, Discacciati A, Mortezavi A, Müller C, Røder A, Rannikko A, Ost P, Eklund M, Lindberg J, Grönberg H, ProBio Investigators. PMID: 42115047 [PubMed - as supplied by publisher]
	Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer. J Immunother Cancer Aggarwal R, Zhang J, Monk P, Zhu X, Jones R, Linch M, Costin D, de Bono J, Karsh LI, Petrylak DP, Zhang L, Deshpande R, Borderies P, Huang J, O'Neill V, Donkor M, Tagawa S. PMID: 42114950 [PubMed - indexed for MEDLINE]
	Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort. Radiother Oncol Guricová KM, van Houdt PJ, Salamanca MF, Schoots IG, Agrotis G, Draulans C, Haustermans K, Smeenk RJ, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp JRN, Pos FJ, van der Heide UA. PMID: 42114601 [PubMed - as supplied by publisher]
	Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial. JCO Precis Oncol Armstrong AJ, Saad F, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Özgüro, Gedye C, Sartor O, Poehlein C, Qiu P, Liu YZ, Li X, Harrington EA, McGuinness D, Kang J, Barnicle A, Clarke N. PMID: 42114035 [PubMed - indexed for MEDLINE]
	Fundamentals of bladder cancer nursing: from diagnosis pathways to holistic care. Br J Nurs Chatterton K. PMID: 42113730 [PubMed - indexed for MEDLINE]
	Holistic nursing care for men with testicular cancer from diagnosis to survivorship. Br J Nurs Hill B. PMID: 42113725 [PubMed - indexed for MEDLINE]
	Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial. JAMA Intern Med Bhasin S, Burnett AL, Gagliano-Jucá T, Storer TW, Reid KF, Shang YV, Privat F, Chandra MS, Weiss M, Memish-Beleva Y, Lam H, Kibel AS, Pencina KM. PMID: 42113507 [PubMed - as supplied by publisher]
	Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy. Technol Cancer Res Treat Iweala EEJ, Nwokoro CP. PMID: 42112707 [PubMed - indexed for MEDLINE]
	A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-Resistant Prostate Cancer. Oncologist Graff JN, Smith CEP, Sokolova AO, Qian DZ, Beer TM, Latour E, Bailey S, Kreitner D, Grivas P, Schweizer MT, Higano CS, Alumkal JJ, Vuky J, Yu EY, Cheng HH. PMID: 42112614 [PubMed - as supplied by publisher]
	Early postoperative complications after open versus laparoscopic radical prostatectomy: a retrospective cohort analysis using Clavien-Dindo classification. J Med Life Cherciu AI, Bumbea AC, Persu MC, Cherciu MM, Firoiu MC, Vrabie RT, Bolovan E, Arbunea DM, Brînzan DM, Ionescu AI, Bratu OG. PMID: 42112219 [PubMed - indexed for MEDLINE]
	Outcomes of pulmonary metastasectomy in urological cancer: insights from a retrospective cohort. PeerJ Yoshino R, Takahashi K, Hatanaka N, Ito A, Ujiie N, Yasuda S, Kitada M. PMID: 42111809 [PubMed - indexed for MEDLINE]
	A case of prostatic urothelial carcinoma with aggressive metastasis: Magnetic resonance imaging as an initial diagnostic clue. Radiol Case Rep Shirai D, Hayakawa N, Morimoto T, Koike J, Kikuchi E. PMID: 42111422 [PubMed]
	Prognostic value of interim post-treatment SPECT/CT following lutetium-177 (177Lu)-PSMA therapy in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. Front Med (Lausanne) Shamshirgaran A, Samadi MH, Aboutalebi F, Zahedian S, Sahafi P, Saeed M, Rizzo A, Treglia G, Sadeghi R, Aghaee A, Askari E. PMID: 42110431 [PubMed]
	Assessing the Efficacy of the Hinotori Robotic System in Prostate Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies. Cureus Mhande Y, Merghat L, M'hamdi Y, Guetbach A. PMID: 42109978 [PubMed]

Articles 1 - 20 / 187740

Page 1 of 9387



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy